Miki Horiguchi

16PUBLICATIONS
36CO-AUTHORS
Epidemiological methodsCancer geneticsPredictive and prognostic markersHaematological tumoursMulticultural education (excl. Aboriginal and Torres Strait Islander, Māori and Pacific Peoples)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 15, 2026
Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation.

|May 07, 2026
Video Education With Clinical Genetic Testing Coordinators for the Rapid Evaluation of Patients With Cancers: Real-World Evidence.

|Oct 14, 2025
Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach.

Miki Horiguchi, Lu Tian, Kenneth L Kehl

|Oct 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Asaf Maoz, Leah Biller, Marios Giannakis

|Apr 11, 2025
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-To-Event Outcomes Using Average Hazard With Survival Weight.

Zihan Qian, Lu Tian, Miki Horiguchi

|Mar 20, 2025
Going Back Home: Understanding the Challenges and Discrimination of Early and Mid-Career International and Puerto Rican Medical Graduates in Oncology Fields in the United States.

Coral Olazagasti, Claudia Villa Celi, Arun Mahtani

Pageof 3

Frequent Collaborators

11 joint publications

Hajime Uno

6 joint publications

Lu Tian

3 joint publications

Satoshi Hattori

2 joint publications

Chinedu Ukaegbu